Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

WIP Simplest Innovation diffusion model from Sterman Business Dynamics Ch9, with Correlation coefficients added, from Taylor TRB et al. (2010)  Improving model understanding using statistical screening WSC paper See also System Dynamics Review 26 (1) p 73-87 and earlier 2005 SDR paper with CCtemplateExcel

This model shows the dynamics of use of a new medical technology based on its scope of use and perceived relative benefit. The technology needs cumulative usage to fix its glitches, and the benefits will be diluted  as the scope of use widens.

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

Simple Bass diffusion modified from Sterman Business Dynamics Ch9, with additional discarding

Simple Bass diffusion modified from Sterman Business Dynamics Ch9, with additional discarding

https://youtu.be/LRlkwN_cFnQ

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

https://en.wikipedia.org/wiki/System_dynamics

https://pt.wikipedia.org/wiki/Din%C3%A2mica_de_sistemas

https://youtu.be/LRlkwN_cFnQ

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584, to which we added churn and duplicated it to model a 2 sided marketplace..

In this 2-sided market model -- take etsy for example --  the adoption rate of end users is also a factor of how many vendors the company has on-boarded.  You can control the impact on end user adoption via the Choice Impact Factor.

Conversely,  the rate at which vendors will be on-boarded is a factor of the perceived opportunity they have to sell their wares.  You can control the rate at which suppliers are on-boarded via the Opportunity Impact Factor.

Copyright 2016 Whatifics Pte Ltd

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

Simple Bass diffusion modified from Sterman Business Dynamics Ch9, with additional discarding

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

Simple Bass diffusion modified from Sterman Business Dynamics Ch9, with additional discarding

Simplest Innovation diffusion model from Sterman Business Dynamics Ch9, with Correlation coefficients added, from Taylor TRB et al. (2010)  Improving model understanding using statistical screening System Dynamics Review 26 (1) p 73-87

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

Clone of model: https://insightmaker.com/insight/610/Diffusion-of-Innovation-Bass-Model

WIP Simplest Innovation diffusion model from Sterman Business Dynamics Ch9, with Correlation coefficients added, from Taylor TRB et al. (2010)  Improving model understanding using statistical screening System Dynamics Review 26 (1) p 73-87

Simple Bass diffusion modified from Sterman Business Dynamics Ch9, with additional discarding

Simple Bass diffusion with repeat purchases, modified from Sterman Business Dynamics Ch9

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

WIP Simplest Innovation diffusion model from Sterman Business Dynamics Ch9, with Correlation coefficients added, from Taylor TRB et al. (2010)  Improving model understanding using statistical screening WSC paper See also System Dynamics Review 26 (1) p 73-87 and earlier 2005 SDR paper with CCtemplateExcel

Simple Bass diffusion modified from Sterman Business Dynamics Ch9. Compare with the SI infectious disease model Insight 584.

This model shows the dynamics of use of a new medical technology based on its scope of use and perceived relative benefit. The technology needs cumulative usage to fix its glitches, and the benefits will be diluted  as the scope of use widens.